Custom Tirzepatide CAS NO: 2023788-19-2 Pricelist, Service
Product Description
Mechanism & Efficacy
Tirzepatide is a dual GLP-1/GIP receptor agonist designed to improve glycemic control, reduce body weight, and support overall metabolic health. It has been studied extensively in clinical trials for type 2 diabetes and obesity management.
Dosage & Clinical Use
Tirzepatide (brand names include Mounjaro®/Zepbound®) is used for glycemic control and weight management, administered as a once‑weekly subcutaneous injection. Available strengths typically include: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg per dose, adjusted based on clinical response and tolerability.
Patents & Intellectual Property
Tirzepatide’s patent portfolio is extensive, involving multiple patents covering the peptide itself, formulations, methods of use, and dosing:
Additional US patents covering methods of glycemic control using optimized dosing regimens also expire through the 2030s. Generic competition for tirzepatide is not expected until at least the mid‑2030s due to this broad patent coverage.
Quality & Compliance
Manufactured under cGMP standards, each batch is rigorously tested for purity, stability, and identity, ensuring research-grade quality suitable for preclinical and clinical studies.
Customer Service & Shipping
Our technical team is available for guidance on peptide handling, storage, and experimental design. We provide temperature-controlled shipping with careful monitoring to ensure product stability during transit.
Therapeutic Areas
A Revolutionary Approach to Weight Management and Metabolic Health
In the evolving health and wellness landscape, the pursuit of effective weight management solutions has led to groundbreaking innovations. One such breakthrough is Tirzepatide, a cutting-edge dual-action therapy designed to support weight management and enhance metabolic health. With its unique mechanism of action, Tirzepatide has the potential to revolutionize the way we address obesity and related metabolic disorders.
Tirzepatide’s innovative design harnesses the body’s natural hormonal pathways to regulate appetite, enhance insulin sensitivity and improve glucose metabolism. By activating GIP and GLP-1 receptors, Tirzepatide helps:
Outlook & Development
Tirzepatide is designed for adults who are obese or overweight, especially those who have not achieved the desired results through lifestyle changes alone. It is suitable for individuals seeking medically assisted weight management, especially those with related metabolic health issues.
As with any medical treatment, safety and effectiveness are of paramount importance. Tirzepatide has gone through rigorous clinical trials to ensure its effectiveness and safety. Patients can work closely with their healthcare provider to determine if Tirzepatide is the right choice for their weight management journey.
Tirzepatide represents a significant advancement in the field of weight management and metabolic health. By simultaneously targeting both the GIP and GLP-1 receptors, this dual-acting therapy offers a comprehensive solution for individuals seeking to improve their health and achieve sustainable weight loss. With Tirzepatide, the path to a healthier lifestyle is no longer just a dream, but a reality waiting to be embraced. Talk to your healthcare provider today to learn more about how Tirzepatide can support your weight management goals and enhance your overall health.
